Beximco Pharmaceuticals Limited (BXP.L)
GBp 38.0
(1.33%)
GBp 38.0
(1.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 44.39 Billion BDT | N/A |
| 2022 | 39.26 Billion BDT | 13.26% |
| 2021 | 34.66 Billion BDT | 17.55% |
| 2020 | 29.49 Billion BDT | 15.16% |
| 2019 | 25.61 Billion BDT | 12.25% |
| 2018 | 22.81 Billion BDT | 28.79% |
| 2017 | 17.71 Billion BDT | 14.24% |
| 2016 | 15.5 Billion BDT | 19.62% |
| 2015 | 12.96 Billion BDT | 15.69% |
| 2014 | 11.2 Billion BDT | 6.83% |
| 2013 | 10.49 Billion BDT | 12.94% |
| 2012 | 9.28 Billion BDT | 17.73% |
| 2011 | 7.89 Billion BDT | 21.56% |
| 2010 | 6.49 Billion BDT | 33.33% |
| 2009 | 4.86 Billion BDT | 21.4% |
| 2008 | 4.01 Billion BDT | 11.49% |
| 2007 | 3.59 Billion BDT | -2.84% |
| 2006 | 3.7 Billion BDT | 11.28% |
| 2005 | 3.32 Billion BDT | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 10.98 Billion BDT | 0.76% |
| 2023 Q1 | 11.15 Billion BDT | 11.22% |
| 2023 Q2 | 10.9 Billion BDT | -2.29% |
| 2022 Q1 | 9.78 Billion BDT | 11.97% |
| 2022 FY | 39.26 Billion BDT | 13.26% |
| 2022 Q4 | 10.03 Billion BDT | 5.02% |
| 2022 Q3 | 9.55 Billion BDT | -3.41% |
| 2022 Q2 | 9.89 Billion BDT | 1.07% |
| 2021 Q4 | 8.74 Billion BDT | -2.44% |
| 2021 Q3 | 8.95 Billion BDT | 5.41% |
| 2021 Q2 | 8.49 Billion BDT | 0.36% |
| 2021 FY | 34.66 Billion BDT | 17.55% |
| 2021 Q1 | 8.46 Billion BDT | 9.55% |
| 2020 Q2 | 7.47 Billion BDT | 7.92% |
| 2020 Q3 | 7.36 Billion BDT | -1.5% |
| 2020 Q4 | 7.73 Billion BDT | 5.01% |
| 2020 Q1 | 6.92 Billion BDT | 6.45% |
| 2020 FY | 29.49 Billion BDT | 15.16% |
| 2019 FY | 25.61 Billion BDT | 12.25% |
| 2019 Q4 | 6.5 Billion BDT | -1.57% |
| 2019 Q3 | 6.61 Billion BDT | 6.75% |
| 2019 Q2 | 6.19 Billion BDT | -1.76% |
| 2019 Q1 | 6.3 Billion BDT | 5.93% |
| 2018 Q4 | 5.95 Billion BDT | 3.36% |
| 2018 FY | 22.81 Billion BDT | 28.79% |
| 2018 Q2 | 5.72 Billion BDT | 6.31% |
| 2018 Q1 | 5.38 Billion BDT | 10.87% |
| 2018 Q3 | 5.75 Billion BDT | 0.56% |
| 2017 Q3 | 4.22 Billion BDT | -3.18% |
| 2017 FY | 17.71 Billion BDT | 14.24% |
| 2017 Q4 | 4.85 Billion BDT | 15.07% |
| 2017 Q2 | 4.35 Billion BDT | 1.9% |
| 2017 Q1 | 4.27 Billion BDT | 5.28% |
| 2016 Q2 | 3.86 Billion BDT | 2.64% |
| 2016 Q1 | 3.76 Billion BDT | 16.12% |
| 2016 Q4 | 4.06 Billion BDT | 6.56% |
| 2016 FY | 15.5 Billion BDT | 19.62% |
| 2016 Q3 | 3.81 Billion BDT | -1.32% |
| 2015 Q4 | 3.24 Billion BDT | -4.54% |
| 2015 Q1 | 3.38 Billion BDT | 4.12% |
| 2015 FY | 12.96 Billion BDT | 15.69% |
| 2015 Q2 | 3.33 Billion BDT | -1.63% |
| 2015 Q3 | 3.39 Billion BDT | 2.0% |
| 2014 Q1 | 2.94 Billion BDT | 7.3% |
| 2014 Q4 | 3.25 Billion BDT | 8.49% |
| 2014 FY | 11.2 Billion BDT | 6.83% |
| 2014 Q2 | 2.93 Billion BDT | -0.28% |
| 2014 Q3 | 2.99 Billion BDT | 2.01% |
| 2013 Q2 | 2.87 Billion BDT | 8.17% |
| 2013 FY | 10.49 Billion BDT | 12.94% |
| 2013 Q4 | 2.74 Billion BDT | 6.59% |
| 2013 Q1 | 2.65 Billion BDT | -1.84% |
| 2013 Q3 | 2.57 Billion BDT | -10.25% |
| 2012 Q4 | 2.7 Billion BDT | 19.46% |
| 2012 Q2 | 2.51 Billion BDT | 3.57% |
| 2012 Q1 | 2.42 Billion BDT | 14.32% |
| 2012 FY | 9.28 Billion BDT | 17.73% |
| 2012 Q3 | 2.26 Billion BDT | -10.01% |
| 2011 Q3 | 2.22 Billion BDT | 5.76% |
| 2011 Q4 | 2.12 Billion BDT | -4.43% |
| 2011 Q2 | 2.1 Billion BDT | -2.11% |
| 2011 FY | 7.89 Billion BDT | 21.56% |
| 2011 Q1 | 2.14 Billion BDT | 8.93% |
| 2010 Q3 | 1.67 Billion BDT | -2.25% |
| 2010 Q1 | 1.81 Billion BDT | 10.35% |
| 2010 FY | 6.49 Billion BDT | 33.33% |
| 2010 Q4 | 1.97 Billion BDT | 17.87% |
| 2010 Q2 | 1.71 Billion BDT | -5.61% |
| 2009 Q4 | 1.64 Billion BDT | 23.78% |
| 2009 Q3 | 1.32 Billion BDT | -4.93% |
| 2009 FY | 4.86 Billion BDT | 21.4% |
| 2009 Q1 | 1.15 Billion BDT | -5.53% |
| 2009 Q2 | 1.39 Billion BDT | 20.48% |
| 2008 Q4 | 1.22 Billion BDT | 12.59% |
| 2008 FY | 4.01 Billion BDT | 11.49% |
| 2008 Q3 | 1.08 Billion BDT | 0.0% |
| 2007 FY | 3.59 Billion BDT | -2.84% |
| 2006 FY | 3.7 Billion BDT | 11.28% |
| 2005 FY | 3.32 Billion BDT | 0.0% |
| Name | Revenue | Revenue Difference |
|---|